GaBI Educational Workshops First ASEAN Educational Workshop on Regulation and Approval of Biosimilars/Similar Biotherapeutic Products 23 July 2017, Amari Watergate, Bangkok, Thailand Professor Kearkiat Praditpornsilpa, MD, Thailand • Division of Nephrology, Department of Medicine, Faculty of Medicine, King Chula- longkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand • Chair of Working Group Biological Products, National List of Essential Medicines Thailand
42
Embed
23 July 2017, Amari Watergate, Bangkok, Thailand Professor ...gabi-journal.net/wp-content/uploads/Kearkiat-V17H23-W.pdf · 23 July 2017, Amari Watergate, Bangkok, Thailand . Professor
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
GaBI Educational Workshops
First ASEAN Educational Workshop on Regulation and Approval of Biosimilars/Similar Biotherapeutic Products
23 July 2017, Amari Watergate, Bangkok, Thailand
Professor Kearkiat Praditpornsilpa, MD, Thailand
• Division of Nephrology, Department of Medicine, Faculty of Medicine, King Chula-longkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
• Chair of Working Group Biological Products, National List of Essential Medicines Thailand
GaBI Educational Workshops
First ASEAN Educational Workshop on Regulation and Approval of Biosimilars/Similar Biotherapeutic Products
23 July 2017, Amari Watergate, Bangkok, Thailand
Clinician’s experience of biocopy EPO in Thailand
Professor Kearkiat Praditpornsilpa, MD
23 July 2017
N = 16,807 Most common haplotypes: HLA-A33-B58-DR17 (4.54%)